Global Metal Non-Covered Biliary Stent Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Adsorbable and Non-Adsorbable

By Drug Class;

Oxazolidinones, Lipopeptides, Cephalosporin, Tetracycline, Folate Antagonist, and Others

By Application;

Malignant Obstruction, Biliary Leaks, Benign Biliary Strictures, and Others

By End User;

Hospitals, Clinics, and Ambulatory Surgical Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn151245341 Published Date: May, 2025 Updated Date: June, 2025

Metal Non-Covered Biliary Stent Market Overview

Metal Non-Covered Biliary Stent Market (USD Million)

Metal Non-Covered Biliary Stent Market was valued at USD 374.11 million in the year 2024. The size of this market is expected to increase to USD 507.07 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.


Global Metal Non-Covered Biliary Stent Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.4 %
Market Size (2024)USD 374.11 Million
Market Size (2031)USD 507.07 Million
Market ConcentrationHigh
Report Pages336
374.11
2024
507.07
2031

Major Players

  • Boston Scientific Corporation
  • Cook Medical LLC
  • Medtronic PLC
  • C. R. Bard, Inc. (acquired by Becton, Dickinson and Company)
  • Taewoong Medical Co., Ltd.
  • CONMED Corporation
  • Biotronik SE & Co. KG
  • EndoChoice Holdings, Inc. (acquired by Boston Scientific Corporation)
  • Merit Medical Systems, Inc.
  • ELLA-CS, s.r.o.
  • E.M.S. Electro Medical Systems S.A.
  • Micro-Tech (Nanjing) Co., Ltd.
  • Hobbs Medical, Inc.
  • Stryker Corporation
  • Olympus Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Metal Non-Covered Biliary Stent Market

Fragmented - Highly competitive market without dominant players


The Metal Non-Covered Biliary Stent Market is emerging as a pivotal area within the medical devices sector, largely fueled by the increasing burden of biliary tract conditions and a growing shift toward minimally invasive procedures. Metal non-covered stents are widely utilized for relieving obstructions in the bile ducts, particularly those caused by malignant strictures. Compared to plastic alternatives, these stents offer longer durability and require fewer replacements, making them a preferred choice in clinical practice. Currently, they represent nearly 65% of the total market for biliary stents, reflecting their widespread adoption.

Rising Demand Due to Cancer-Related Biliary Obstruction

A major driver for this market is the increasing occurrence of hepatobiliary cancers and pancreatic malignancies, which are common causes of bile duct blockages. Metal stents are chosen in more than 70% of such cases due to their longer patency and superior palliative outcomes. Continuous innovation in stent design—such as enhanced radial strength, improved anti-migration technology, and more efficient delivery systems—is improving patient outcomes and enabling the use of these stents in more complex scenarios.

Clinical Efficiency and Preference in Endoscopy

Clinicians favor metal non-covered stents for their biocompatibility and reduced risk of causing tissue overgrowth, especially in cases where maintaining side-branch patency is essential. Though they do not have a tumor-blocking membrane like their covered counterparts, their strategic design makes them ideal for certain anatomical requirements. Currently, about 60% of malignant biliary obstruction procedures incorporate these stents, underscoring their clinical significance in therapeutic endoscopy. Their quick bile drainage capability and ability to shorten hospital stays further boost their clinical and economic value.

Technology Advancements and Cost-Efficiency Trends

Ongoing advancements in endoscopic techniques and the global push toward cost-effective, patient-centric care are reinforcing the demand for metal non-covered stents. Healthcare providers, including hospitals and outpatient surgical centers, increasingly prioritize long-lasting, low-maintenance solutions. Manufacturers are responding with stents that are easier to deploy and designed for long-term patency with fewer complications. With these innovations, the market continues to show strong growth potential, driven by a blend of clinical reliability, procedural convenience, and the broader adoption of non-invasive treatment strategies.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Drug Class
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Metal Non-Covered Biliary Stent Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of biliary disorders
        2. Surge in minimally invasive procedures
        3. Favorable reimbursement policies
        4. Demand for long-term palliative care solutions
      2. Restraints
        1. Stringent regulatory approval
        2. Stent-related complications risk
        3. Limited skilled healthcare workforce
        4. Durability and efficacy concerns
        5. Ethical dilemmas in end-of-life care
      3. Opportunities
        1. Adoption of value-based healthcare
        2. Integration of digital health solutions
        3. Tailored product offerings
        4. Physician training investments
        5. Patient-centric services development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Metal Non-Covered Biliary Stent Market, By Type, 2021 - 2031 (USD Million)
      1. Adsorbable
      2. Non-adsorbable
    2. Metal Non-Covered Biliary Stent Market, By Drug Class, 2021 - 2031 (USD Million)
      1. Oxazolidinones
      2. Lipopeptides
      3. Cephalosporin
      4. Tetracycline
      5. Folate Antagonist
      6. Others
    3. Metal Non-Covered Biliary Stent Market, By Application, 2021 - 2031 (USD Million)
      1. Malignant Obstruction
      2. Biliary Leaks
      3. Benign Biliary Strictures
      4. Others
    4. Metal Non-Covered Biliary Stent Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
    5. Metal Non-Covered Biliary Stent Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. Cook Medical LLC
      3. Medtronic PLC
      4. C. R. Bard, Inc. (acquired by Becton, Dickinson and Company)
      5. Taewoong Medical Co., Ltd.
      6. CONMED Corporation
      7. Biotronik SE & Co. KG
      8. EndoChoice Holdings, Inc. (acquired by Boston Scientific Corporation)
      9. Merit Medical Systems, Inc.
      10. ELLA-CS, s.r.o.
      11. E.M.S. Electro Medical Systems S.A.
      12. Micro-Tech (Nanjing) Co., Ltd.
      13. Hobbs Medical, Inc.
      14. Stryker Corporation
      15. Olympus Corporation
  7. Analyst Views
  8. Future Outlook of the Market